Intended Use

Software intended to aid in earlier detection of Left Ventricular Ejection Fraction (LVEF) less than or equal to 40% in adults at risk for heart failure, including patients with cardiomyopathies, post-myocardial infarction, aortic stenosis, chronic atrial fibrillation, cardiotoxic pharmaceutical therapies, and postpartum women.

Technology

AI-based software interprets 12-lead ECG voltage time series data from a 10-second acquisition using a machine learning algorithm to output the likelihood of low LVEF (≤ 40%). Delivered as a software module in a Docker container, it integrates into third-party clinical systems (EMR or ECG management systems) and provides binary results via API without a direct GUI. It supports 12-lead ECG devices with 500 Hz digital output.

Performance

The device underwent software verification and labeling verification. It includes a Predetermined Change Control Plan allowing periodic software updates validated by multicenter retrospective clinical studies with new data to enhance sensitivity and specificity. Equivalence to predicate device demonstrated by non-clinical verification, ensuring safety and effectiveness.

Predicate Devices

No predicate devices specified

Ready to Sharpen Your Edge?

Subscribe to join 11k+ peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.